Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Sofinnova Partners Sas Insider Profile
4 Followers
Sofinnova Partners Sas, Ten Percent Owner at Flexion Therapeutics, holds 2.10M shares in Flexion Therapeutics (Ticker: FLXN). Most recently, Sofinnova Partners Sas Sold $10,000 shares of Flexion Therapeutics on Jan 19, 2015 for an estimated value of 200.00K.
Sofinnova Partners Sas Flexion Therapeutics (FLXN)Ten Percent Owner
Flexion Therapeutics (FLXN)
Ten Percent Owner
Ranked #26,721 out of 78,624 Corporate Insiders
Profitable Transactions
2 out of 2 Profitable Transactions
Average Return
+42.20%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Sofinnova Partners Sas's holdings
Insider Roles
Ten Percent Owner
Roles that Sofinnova Partners Sas holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Feb 20, 2014 - Feb 20, 2015
Return:+51.10%
The most profitable trade made by Sofinnova Partners Sas
Sofinnova Partners Sas's Trading History
List of latest transactions for each holding click on a transaction to see Sofinnova Partners Sas's performance on stock
You May Also Like
Sofinnova Partners Sas insider profile FAQ
What is the percentage of profitable transactions made by Sofinnova Partners Sas?
The percentage of profitable transactions made by Sofinnova Partners Sas is 100%.
What is the average return per transaction made by Sofinnova Partners Sas?
The average return per transaction made by Sofinnova Partners Sas is 42.20%.
What stocks does Sofinnova Partners Sas hold?
Sofinnova Partners Sas holds: FLXN stocks.
What was Sofinnova Partners Sas’s latest transaction?
Sofinnova Partners Sas latest transaction was an Informative Sell of $200.00K.
What was Sofinnova Partners Sas's most profitable transaction?
Sofinnova Partners Sas’s most profitable transaction was an Informative Buy of FLXN stock on February 20, 2014. The return on the trade was 51.10%.
What is Sofinnova Partners Sas's role in Flexion Therapeutics?
Sofinnova Partners Sas's role in Flexion Therapeutics is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.